CURR CANCER DRUG TAR 潤色咨詢

CURRENT CANCER DRUG TARGETS

出版年份:2001 年文章數(shù):1180 投稿命中率: 開通期刊會員,數(shù)據(jù)隨心看

出版周期:Monthly 自引率:1.2% 審稿周期: 開通期刊會員,數(shù)據(jù)隨心看

前往期刊查詢

投稿信息

投稿信息
審稿費(fèi)用
暫無數(shù)據(jù)
版面費(fèi)用
暫無數(shù)據(jù)
中國人發(fā)表比例
2023年中國人文章占該期刊總數(shù)量48.00% (2022年為42.65%)
自引率
1.2 %
年文章數(shù)
1180
期刊官網(wǎng)
點(diǎn)擊查看 (點(diǎn)擊次數(shù):9335)
投稿鏈接
點(diǎn)擊查看 (點(diǎn)擊次數(shù):2137次)
作者需知
點(diǎn)擊查看 (點(diǎn)擊次數(shù):746次)
期刊簡介
稿件收錄要求

Published by Bentham Science Publishers. ISSN: 1568-0096.

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.

Current Cancer Drug Targets publishes original research articles, letters, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.

As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.